The long bubble lifetime is the result of surfactant-induced surface tension changes.

In the present study, we report that surfactant-associated protein-35 is also sulfated.

However, administration of surfactant is currently not advised in adult respiratory failure.

He was given surfactant, a March of Dimes-funded treatment, to help him breathe.

It may have clinical implications on future application and development of surfactant preparations.

Biophysical studies suggest that surfactant inhibition is partially responsible for this unsatisfactory performance.

Overall, administration of surfactant appeared to increase the probability of a favorable outcome.

We conclude that capillary pressure and surfactant secretion are mechanically coupled.

Stretching of alveoli during lung inflation is the main trigger for surfactant secretion.

It is expected that as the surfactant concentration increases the surface tension decreases.

Treatment with exogenous surfactant may decrease the incidence or severity of bronchopulmonary dysplasia.

The copolymer displays bacteria-activated surfactant-like properties, resulting from contact with the bacterial envelope.

This acts as a surfactant, and disrupts the lipid layer around virus particles.

Therefore, the gas transfer characteristics of lung surfactant film are of fundamental physiological interest.

Under such conditions surfactant components might be catabolized by bacteria and promote bacterial growth.

Conclusion: The surfactant was demonstrated to be safe and effective as carrier of Levofloxacin.